Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The chromosome 17 open reading frame 51 pseudogene (ENSG00000266885) is a segment of DNA on human chromosome 17 that is annotated as a processed pseudogene. Pseudogenes are classified as genetic elements that closely resemble functional genes but have lost the ability to encode functional proteins due to disabling mutations or lack of regulatory elements. Processed pseudogenes, specifically, typically originate from reverse-transcribed mRNA integrated back into the genome, lack introns and their own promoters, and are usually transcriptionally inactive. This pseudogene does not perform known biological functions and is not associated with disease, drug interaction, or established as a clinical biomarker. Pseudogenes like ENSG00000266885 may, in rare cases, participate in gene regulation or be transcribed at low levels, but current scientific evidence does not ascribe any such function to this particular locus. Its primary significance is as a relic of genome evolution and gene duplication/retrotransposition events.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 17 open reading frame 51 pseudogene.